{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "North Blenheim",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "84657",
      "recalling_firm": "Denton Pharma, Inc.",
      "address_1": "119 Creamery Rd",
      "address_2": "",
      "postal_code": "12131-1613",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0795-2020",
      "product_description": "Ranitidine Tablets, USP 300 mg a). 15-count bottles (NDC 70934-287-15), b). 90-count bottles (NDC 70934-287-90), Rx Only, Repackaged by: Northwind Pharmaceuticals North Brenheim, NY 12131",
      "product_quantity": "467 bottles",
      "reason_for_recall": "CGMP Deviations: Presence of NDMA impurity detected in product.",
      "recall_initiation_date": "20191220",
      "center_classification_date": "20200120",
      "termination_date": "20231005",
      "report_date": "20200129",
      "code_info": "a). N106851901, Exp. 11/30/2021       N106851902, Exp. 10/31/2021    b). C106851901, Exp. 11/30/2021       C106851902  Exp. 10/31/2021       C106851903  Exp. 02/28/2022       C106851904  Exp. 11/30/2021       C106851905  Exp. 05/31/2022",
      "more_code_info": ""
    }
  ]
}